Instalab

BUN/Creatinine Test

Spot hidden kidney stress, dehydration, or muscle breakdown that standard kidney tests alone can miss.

Should you take a BUN/Creatinine test?

This test is most useful if any of these apply to you.

Watching Over Your Kidneys
If you have diabetes, high blood pressure, or kidney disease in the family, this ratio catches early shifts a standard creatinine alone can miss.
Concerned About Heart Risk
An elevated ratio predicts cardiovascular death even when kidney function looks normal, adding risk information beyond standard heart panels.
Eating High Protein or Training Hard
If you eat a high-protein diet or train intensely, this ratio helps confirm your kidneys are handling the extra workload without strain.
Over 60 and Staying Ahead
Aging reduces kidney reserve while creatinine stays deceptively normal due to muscle loss; the ratio reveals what creatinine alone hides.

About BUN/Creatinine

Your kidneys silently filter about 50 gallons of blood every day, and the BUN/Creatinine ratio is one of the fastest ways to check whether that system is under strain. This single number combines two different waste products, each telling its own story, and the relationship between them can reveal problems that neither measurement catches on its own.

What makes this ratio especially useful is that it picks up signals beyond straightforward kidney disease. An abnormal ratio can flag dehydration, internal bleeding, excessive muscle breakdown, heart failure, or a body that is burning through its own protein stores. For anyone tracking their health over time, it is a surprisingly information-dense number.

What BUN and Creatinine Actually Measure

BUN (blood urea nitrogen) is a waste product your liver creates when it breaks down protein, whether from food or from your own tissues. Urea is small enough to pass freely through the kidneys' filters, and your body uses it as its main way to get rid of excess nitrogen. Your BUN level reflects both how much protein your body is processing and how well your kidneys are clearing the waste.

Creatinine comes from a completely different source: your muscles. It is a byproduct of creatine phosphate, the energy molecule your muscles burn constantly. Because creatinine production is tied closely to your muscle mass, it stays relatively stable day to day in the same person. Your kidneys filter it out of the blood without reabsorbing it, which is why doctors use creatinine as a rough proxy for how well the kidneys' filters are working.

The ratio between these two numbers matters because BUN and creatinine respond to different conditions. When something shifts BUN without changing creatinine (or vice versa), the ratio tilts, and that tilt often points to a specific problem.

What a High Ratio Means

A BUN/Creatinine ratio above 20 has traditionally been taught as a sign of "prerenal" kidney stress, meaning the kidneys themselves are fine but are not receiving enough blood flow, typically from dehydration or heart failure. Recent evidence has complicated this picture significantly. In critically ill patients, a ratio above 20 at ICU admission was associated with a 60% higher risk of dying in the hospital. Rather than indicating a reversible, benign condition, the elevated ratio appears to reflect protein breakdown and metabolic stress.

In hospitalized patients with chronic kidney disease (CKD), elevated ratios are linked to older age, heart failure, gastrointestinal bleeding, acute kidney injury, lower albumin levels, higher rates of death during the hospital stay, and greater likelihood of being readmitted within 30 days. Other common causes of a high ratio include dehydration, high protein intake, upper gastrointestinal bleeding, corticosteroid use, and an overactive thyroid.

In a national U.S. dataset (NHANES) of 10,604 adults, people with an elevated BUN/Creatinine ratio who did not have metabolic syndrome were about twice as likely to die from coronary heart disease compared to those with a normal ratio. The study did not find a statistically significant link between an elevated ratio combined with metabolic syndrome and CHD mortality, suggesting the ratio may carry independent prognostic information regardless of metabolic status.

A ratio below 10 suggests either that BUN is unusually low or creatinine is disproportionately high. Low BUN can result from severe liver disease (because the liver can no longer manufacture urea efficiently), malnutrition, or very low protein intake. High creatinine without a matching BUN rise can signal muscle breakdown (a condition called rhabdomyolysis) or certain kidney injuries that affect the tissue between the kidney's filtering units.

One study found that a BUN/Creatinine ratio of 12 or below had 76% sensitivity and 81% specificity for identifying acute interstitial nephritis (inflammation of the kidney's support tissue) in patients with acute kidney injury. That means it correctly flagged about three out of four true cases while correctly clearing about four out of five people who did not have the condition.

Heart Disease and Cardiovascular Risk

The ratio carries surprisingly strong prognostic information for heart disease. In a secondary analysis of the TOPCAT heart failure trial involving 1,521 participants with a type of heart failure where the heart pumps normally but fills poorly (called HFpEF), a higher BUN/Creatinine ratio was associated with roughly 50% higher all-cause mortality and about 80% higher cardiovascular mortality after full statistical adjustment.

In a national U.S. dataset (NHANES) of 10,604 adults, people with an elevated BUN/Creatinine ratio who did not have metabolic syndrome were about twice as likely to die from coronary heart disease compared to those with a normal ratio. When the elevated ratio combined with metabolic syndrome, the risk climbed to nearly three times higher.

Mortality Risk Across Populations

Elevated BUN and BUN/Creatinine ratio independently predict death across a wide range of clinical settings. The strength and consistency of this association is striking.

Who Was StudiedWhat Was ComparedWhat They Found
10,507 adults with diabetes, followed for yearsHighest vs. lowest BUN groupAbout 50% higher cardiovascular death risk and 35% higher all-cause death risk
4,883 Taiwanese adults followed for about 8 yearsBUN at or above 20 mg/dL vs. belowAbout 50% higher all-cause mortality; nearly 90% higher cardiovascular mortality
383 older Veterans followed up to 9 yearsBUN at or above 30 mg/dL vs. belowAbout 50% higher death risk after adjusting for other factors

What this means for you: even within the "normal" range, higher BUN levels appear to carry meaningful risk. Mortality data from cardiovascular disease populations suggest that risk begins to climb at BUN levels as low as 16 to 17 mg/dL and creatinine levels around 1.0 to 1.1 mg/dL, values that most standard lab reports would not flag.

Stroke Risk

In the Dongfeng-Tongji cohort of nearly 27,000 participants followed for about 8 years, the relationship between BUN/Creatinine and stroke risk followed a U-shaped pattern. People in the lowest fifth of the ratio had about a 19% higher risk of total stroke and a 26% higher risk of the most common type (ischemic stroke) compared to those in the middle range. These associations held even when analysis was restricted to people whose BUN fell within the clinically normal range.

Type 2 Diabetes Risk

A large retrospective study of 189,416 Chinese adults found that higher BUN/Creatinine ratios predicted new-onset type 2 diabetes. Compared to those in the lowest quarter (ratio at or below 13.5), people in the highest quarter (ratio above 19.6) were about 39% more likely to develop diabetes. Those with a ratio at or above 20 had about a 30% higher risk compared to those below 20.

Critical Illness and ICU Outcomes

In critical care settings, the BUN/Creatinine ratio has emerged as a marker of protein catabolism, the body's tendency to break down its own muscle and tissue during severe illness. A scoping review and meta-analysis found that the ratio correlates with reduced muscle area and extended ICU stays. In patients with acute kidney injury receiving continuous dialysis, a J-shaped relationship exists: mortality increases sharply once the ratio exceeds 15.

Among 2,702 ICU patients with ischemic stroke, each one-unit increase in the BUN/Creatinine ratio was associated with a 1.4% increase in the chance of dying within 28 days. In atrial fibrillation patients, the ratio showed a U-shaped mortality curve with the lowest risk at a ratio around 16.5.

A Traditional Diagnostic Use That Doesn't Hold Up

For decades, medical students learned that a BUN/Creatinine ratio above 20 means the kidneys are just dehydrated and will bounce back once fluids are given. The evidence does not support this. In a study of 1,103 emergency department patients with acute kidney injury, the ratio showed no ability to distinguish between a dehydrated kidney and a damaged one (the statistical test for accuracy scored 0.5, which is no better than flipping a coin).

This matters for you because if a doctor dismisses your high ratio as "just dehydration" without further investigation, the evidence suggests that approach may miss important signals. The ratio is far more valuable as a risk marker for outcomes and catabolic stress than as a diagnostic tool for pinpointing the cause of acute kidney injury. For that purpose, urine-based tests like fractional excretion of sodium perform significantly better.

Reference Ranges

BUN and creatinine values vary substantially by age, sex, muscle mass, and ethnicity, so interpreting your ratio requires knowing where your individual components fall. Creatinine ranges differ by sex because men typically have more muscle mass.

ComponentTypical Adult RangeNotes
BUN7 to 20 mg/dLIncreases about 0.6 to 0.8 mg/dL per decade of age; males tend higher than females
Creatinine (men)0.63 to 1.16 mg/dLHigher in people with greater muscle mass; non-Hispanic Black adults average about 1.25 mg/dL
Creatinine (women)0.48 to 0.93 mg/dLLower muscle mass produces lower baseline levels; non-Hispanic Black women average about 1.01 mg/dL
BUN/Creatinine Ratio10 to 20Values outside this range warrant investigation; mortality data suggests risk rises at the high end even within this range

These ranges are drawn from published population studies using standardized assays. Your lab may report slightly different reference intervals depending on the method used. The most meaningful comparison is always your own trend over time within the same lab.

For a prevention-focused perspective, mortality data suggests that keeping BUN below about 16 to 17 mg/dL and creatinine below about 1.0 mg/dL (for those with cardiovascular risk factors) may represent a more optimal target than simply staying below the upper limit of "normal." The ratio itself appears safest around 15 to 17 based on U-shaped mortality curves from large datasets.

Why a Single Reading Can Fool You

BUN fluctuates significantly from day to day. Its within-person coefficient of variation (a measure of how much a lab value naturally bounces around in the same healthy person) is about 11 to 12%, roughly double that of creatinine (about 4.4 to 5.0%). That means BUN can shift by more than 10% between two blood draws taken under identical conditions, purely from biological variability.

Creatinine is more stable but still has traps. Eating a serving of cooked beef can raise your creatinine by about 0.05 to 0.07 mg/dL within two hours, and one study showed that 6 out of 16 patients with moderate kidney disease were reclassified into a worse stage after eating a meat meal. The effect disappears after about 12 hours of fasting.

Dehydration pushes BUN up more than creatinine, artificially inflating the ratio. Intense exercise can transiently raise creatinine through both muscle breakdown and reduced kidney blood flow. A recent fever or illness can spike BUN through increased protein breakdown. Even the time of day matters: creatinine shows higher variability in healthy people (about 6.4%) than in those with kidney disease (about 2.5%), partly because diet has a bigger proportional impact when baseline levels are low.

Medications That Distort the Picture

Several common medications raise creatinine without actually harming the kidneys, a phenomenon sometimes called "pseudo-AKI." Trimethoprim (an antibiotic often prescribed for urinary tract infections), cimetidine (a stomach acid reducer), and certain HIV medications block the kidney's tubular secretion of creatinine, making it look like your kidney function has worsened when it has not. If you are taking any of these and your creatinine rises, the medication is likely the cause, not your kidneys.

On the BUN side, corticosteroids increase protein breakdown and can push BUN up independently of kidney function. An overactive thyroid does the same through accelerated metabolism, raising BUN while simultaneously lowering creatinine, which can dramatically inflate the ratio. The effect normalizes completely once thyroid function is treated.

Tracking Your Trend

Given the natural variability in both BUN and creatinine, a single reading is a starting point, not an answer. The minimum change in creatinine that represents a true biological shift rather than random noise is about 18%. For estimated kidney filtration rate (eGFR, a formula-based score derived from creatinine), you need to see a change of at least 12 to 16% before you can be confident something real has happened.

Get a baseline BUN/Creatinine ratio as part of your first full blood panel. If you are making dietary changes, starting a new supplement, or adjusting medications that could affect kidney function, retest in 3 to 6 months. Once you have a stable baseline, annual testing is the minimum. If you have diabetes, hypertension, heart disease, or are over 60, test at least once a year and more often if values are trending in the wrong direction.

Always compare results from the same lab. Different labs use different assay methods, and even small differences in calibration can shift your creatinine enough to change the ratio. Your trend line within one lab is the most reliable information you have.

What Moves This Biomarker

Evidence-backed interventions that affect your BUN/Creatinine level

Up & Down
Start an SGLT2 inhibitor (such as canagliflozin, empagliflozin, or dapagliflozin) if you have diabetes or CKD.
Creatinine rises modestly in the first few weeks (reflecting an initial eGFR dip of about 3 to 5 mL/min), then long-term kidney function is preserved. In the CREDENCE trial, canagliflozin reduced the risk of doubling serum creatinine by 40% over a median of 2.6 years. The EMPA-REG OUTCOME trial showed a 46% reduction in the combined risk of creatinine doubling, dialysis, or kidney death.
MedicationStrong Evidence
Up & Down
Start an ACE inhibitor (such as enalapril) or ARB (such as losartan or irbesartan) if you have high blood pressure or protein in your urine.
Creatinine may rise up to 30% within the first two weeks of starting, then long-term kidney function is preserved. The RENAAL trial showed losartan reduced the risk of needing dialysis by 28% in diabetic kidney disease. Irbesartan reduced the risk of creatinine doubling by 23% compared to placebo.
MedicationStrong Evidence
Decrease
Reduce your daily protein intake to about 0.6 to 0.8 grams per kilogram of body weight, under guidance from a dietitian.
A 24-week randomized trial in people with stage 3 to 4 CKD showed that individualized low-protein diet therapy (0.75 g/kg/day) significantly reduced serum creatinine and slowed BUN increases compared to standard care.
DietModerate Evidence
Decrease
Do regular aerobic exercise (walking, running, or cycling) for at least 30 minutes per session.
A meta-analysis of 12 randomized trials found that aerobic exercise significantly lowered both serum creatinine and BUN in CKD patients, with walking and running outperforming cycling for creatinine improvement. A separate meta-analysis of 11 trials over an average of 35 weeks showed eGFR improved by about 2.16 mL/min.
ExerciseModerate Evidence
Decrease
Take a probiotic, prebiotic, or synbiotic supplement daily.
A meta-analysis of 13 randomized trials showed these supplements decreased BUN by about 1.72 mmol/L (roughly 4.8 mg/dL). Prebiotics specifically also reduced serum creatinine.
SupplementModerate Evidence
Increase
Quit smoking if you currently smoke.
Smoking cessation slows the long-term decline in kidney function. In the KNOW-CKD study of 1,951 patients, those with 30 or more pack-years of smoking had about a 94% higher risk of CKD progression compared to never-smokers. Longer cessation periods showed graded benefit. This study measured CKD progression rather than the BUN/Creatinine ratio directly, but preserved kidney function would be expected to keep both BUN and creatinine in a healthier range.
LifestyleModerate Evidence
Decrease
Take resveratrol at doses of 500 mg per day or less.
A meta-analysis of randomized trials found resveratrol at doses up to 500 mg/day significantly lowered both serum creatinine and BUN. The most significant effects were seen in people with diabetes.
SupplementModest Evidence
Decrease
Limit your sodium intake to less than 2 grams per day.
Sodium restriction reduces blood pressure and proteinuria, both of which contribute to kidney function preservation. KDIGO guidelines recommend this as a standard part of kidney-protective dietary strategy. The effect on the BUN/Creatinine ratio itself has not been directly studied in trials.
DietModest Evidence

Frequently Asked Questions

References

52 studies
  1. BUN (Blood Urea Nitrogen)
    National Library of MedicineMedlineplus
  2. Wang H, Ran J, Jiang TSub-cellular Biochemistry2014
  3. Creatinine Test
    National Library of MedicineMedlineplus
  4. Stevens LA, Coresh J, Greene T, Levey ASThe New England Journal of Medicine2006
  5. Jurado R, Mattix HArchives of Internal Medicine1998